1Marsh MN (1992) Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 102, 330–354.
2Sollid LM (2002) Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2, 647–655.
3Gianfrani C, Auricchio S & Troncone R (2005) Adaptive and innate immune responses in celiac disease. Immunol Lett 99, 141–145.
4Cinova J, Palová-Jelínková L, Smythies LE, et al. (2007) Gliadin peptides activate blood monocytes from patients with celiac disease. J Clin Immunol 27, 201–209.
5Cosnes J, Cellier C, Viola S, et al. (2008) Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol 6, 753–758.
6Malandrino N, Capristo E, Farnetti S, et al. (2008) Metabolic and nutritional features in adult celiac patients. Dig Dis 26, 128–133.
7Nadal I, Donat E, Ribes-Koninckx C, et al. (2007) Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J Med Microbiol 56, 1669–1674.
8Sanz Y, Sánchez E, De Palma G, et al. (2008) . In Child Nutrition and Physiology, pp. 210–224 [Overton LT and Ewente MR, editors]. Hauppauge, NY: Nova Science Publishers.
9Elder JH, Shankar M, Shuster J, et al. (2006) The gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trial. J Autism Dev Disord 36, 413–420.
10Farran A, Zamora R & Cervera P (2004) Tablas de Composición de Alimentos CESNID (CESNID Food Composition Tables), 2nd ed.Barcelona: McGraw-Hill/Interamericana.
11Collado MC, Calabuig M & Sanz Y (2007) Differences between the fecal microbiota of coeliac infants and healthy controls. Curr Issues Intest Microbiol 8, 9–14.
12Amann RI, Binder BJ, Olson RJ, et al. (1990) Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 56, 1919–1925.
13Harmsen HJM, Wildeboer-Veloo AC, Grijpstra J, et al. (2000) Development of 16S rRNA based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age. Appl Environ Microbiol 66, 4523–4527.
14Langendijk PS, Schut F, Jansen GJ, et al. (1995) Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 61, 3069–3075.
15Harmsen HJH, Gibson GR, Elfferich P, et al. (1999) Comparison of viable cell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human fecal bacteria. FEMS Microbiol Lett 183, 125–129.
16Manz W, Amann R, Ludwig W, et al. (1996) Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum Cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 142, 1097–1106.
17Poulsen LK, Lan F, Kristensen CS, et al. (1994) Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun 62, 5191–5194.
18Franks AH, Harmsen HJM, Raangs GC, et al. (1998) Variations of bacterial populations in human faeces measured by fluorescent in situ hybridization with group specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64, 3336–3345.
19Hold GL, Schwiertz A, Aminov RI, et al. (2003) Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 69, 4320–4324.
20Suau A, Rochet V, Sghir A, et al. (2001) Fusobacterium prausnitzii and related species represent a dominant group within the human fecal flora. Syst Appl Microbiol 24, 139–145.
21Wallner G, Amann R & Beisker W (1993) Optimizing fluorescent in situ hybridization with rRNA-targeted oligonucleotide probes for flow cytometric identification of microorganisms. Cytometry 14, 136–143.
22Collado MC & Sanz Y (2007) Quantification of mucosa-adhered microbiota of lambs and calves by the use of culture methods and fluorescent in situ hybridization coupled with flow cytometry techniques. Vet Microbiol 121, 299–306.
23Matsuki T, Watanabe K, Fujimoto J, et al. (2002) Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 68, 5445–5451.
24Malinen E, Kassinen A, Rinttilä T, et al. (2003) Comparison of real-time PCR with SYBR Green I or 5′-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 149, 269–277.
25Medina M, Izquierdo E, Ennahar S, et al. (2007) Differential immunomodulatory properties of Bifidobacterium longum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol 150, 531–538.
26Kinsey L, Burden ST & Bannerman E (2008) A dietary survey to determine if patients with coeliac disease are meeting current healthy eating guidelines and how their diet compares to that of the British general population. Eur J Clin Nutr 62, 1333–1342.
27De Graaf AA & Venema K (2008) Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Adv Microb Physiol 53, 73–168.
28Collado MC, Donat E, Ribes-Koninckx C, et al. (2009) Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J Clin Pathol 62, 264–269.
29Swidsinski A, Loening-Baucke V, Vaneechoutte M, et al. (2007) Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 14, 147–161.
30Schell MA, Karmirantzou M, Snel B, et al. (2002) The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci U S A 99, 14422–14427.
31Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56, 1–26.